Avista buys the Spanish dental prosthesis provider Terrats Medical
New York-based US personal fairness agency Avista Capital Companions has acquired Terrats Medical, a provider of dental prostheses, abutments and implants, from Miura Companions.
Monetary phrases of the deal weren’t disclosed.
Based in 1947, Terrats Medical is a Spain-based firm specializing within the manufacturing and advertising and marketing of a variety of dental prostheses and associated merchandise.
The corporate's buyer base contains dental practices, laboratories, distributors and producers of unique dental implant gear that buy Terrats merchandise on a non-public label foundation.
Terrats Medical has a powerful worldwide presence, with exports accounting for greater than 95% of gross sales and gross sales in additional than 50 nations.
Miura Companions has been investing in Terrats since 2020 and helps Terrats in implementing varied strategic initiatives which have tripled its whole turnover.
Achieve entry to probably the most complete firm profiles in the marketplace, powered by GlobalData. Save hours of analysis. Achieve aggressive benefit.
Firm Profile – Free Pattern
Your obtain e-mail will arrive shortly
We’ve got confidence within the distinctive high quality of our firm profiles. Nonetheless, we wish you to take advantage of useful determination for your enterprise. That's why we give you a free pattern which you can obtain by submitting the shape beneath.
By GlobalData
A few of these initiatives embrace enhancing direct gross sales with the DESS Dental Sensible Options model, launching an implantology enterprise, advancing its digital technique and buying distributors Geryon within the US and Sweden's Humanus Dental.
Avista's acquisition of Terrats is anticipated to assist Terrats' progress within the worldwide market, particularly within the US.
It should additionally assist strengthen Terrats' monetary and world positioning, enabling additional enlargement and exploration of recent inorganic progress alternatives.
The founders of Terrats Medical have reinvested within the firm and can proceed to guide the corporate after the acquisition.
Miura has additionally reinvested in Terrats, demonstrating its continued assist for the longer term progress of Terrats Medical.
Advisory companies for the transaction had been offered to Miura by Moelis & Firm for mergers and acquisitions, KPMG for due diligence and Clifford Probability for authorized recommendation.
Deloitte offered due diligence companies for Avista, whereas Ropes & Grey and Uría offered authorized recommendation on the transaction.
Terrats CEO Roger Terrats mentioned: “Our imaginative and prescient for the following section will probably be very constant and centered on world progress, with a best-in-class product providing and a powerful gross sales community that will probably be strengthened within the coming years. As well as, we look ahead to persevering with to spend money on our manufacturing and our staff.”
